Helsinn Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HELSINN HLTHCARE, and when can generic versions of HELSINN HLTHCARE drugs launch?
HELSINN HLTHCARE has five approved drugs.
There are thirty-eight US patents protecting HELSINN HLTHCARE drugs.
There are three hundred and forty-five patent family members on HELSINN HLTHCARE drugs in fifty-nine countries and twenty-three supplementary protection certificates in fourteen countries.
Summary for Helsinn Hlthcare
| International Patents: | 345 |
| US Patents: | 38 |
| Tradenames: | 3 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Helsinn Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | RX | Yes | Yes | 10,233,154 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Helsinn Hlthcare | AKYNZEO | fosnetupitant chloride hydrochloride; palonosetron hydrochloride | SOLUTION;INTRAVENOUS | 210493-002 | May 27, 2020 | RX | Yes | Yes | 10,624,911 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Helsinn Hlthcare | TRUSELTIQ | infigratinib phosphate | CAPSULE;ORAL | 214622-001 | May 28, 2021 | DISCN | Yes | No | 11,160,804 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Helsinn Hlthcare | TRUSELTIQ | infigratinib phosphate | CAPSULE;ORAL | 214622-001 | May 28, 2021 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | DISCN | Yes | No | 7,947,725*PED | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Helsinn Hlthcare | AKYNZEO | fosnetupitant chloride hydrochloride; palonosetron hydrochloride | POWDER;INTRAVENOUS | 210493-001 | Apr 19, 2018 | DISCN | Yes | No | 11,312,698 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | CAPSULE;ORAL | 022233-001 | Aug 22, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Helsinn Hlthcare
International Patents for Helsinn Hlthcare Drugs
Supplementary Protection Certificates for Helsinn Hlthcare Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2785706 | LUC00158 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: AKYNZEO - FOSNETUPITANT/PALONOSETRON; AUTHORISATION NUMBER AND DATE: EU/1/15/1001 20200318 |
| 2785706 | 2090015-5 | Sweden | ⤷ Sign Up | PRODUCT NAME: FOSNETUPITANT; REG. NO/DATE: EU/1/15/1001 20200317 |
| 2785706 | C20200029 00371 | Estonia | ⤷ Sign Up | PRODUCT NAME: FOSNETUPITANT;REG NO/DATE: EU/1/15/1001; 18.03.2020 |
| 2785706 | 2020C/516 | Belgium | ⤷ Sign Up | PRODUCT NAME: AKYNZEO - FOSNETUPITANT/PALONOSETRON; AUTHORISATION NUMBER AND DATE: EU/1/15/1001 20200318 |
| 2785706 | 2020030 | Norway | ⤷ Sign Up | PRODUCT NAME: FOSNETUPITANT OG FARMASOEYTISK AKSEPTABLE SALTER OG SOLVATER DERAV SPESIELT FOSNETUPITANT KLORID HYDROKLORID; REG. NO/DATE: EU/1/15/1001 20200318 |
| 1035115 | CA 2015 00044 | Denmark | ⤷ Sign Up | PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150527 |
| 1035115 | 92745 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: NETUPITANT/PALONOSETRON ET LEURS DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (AKYNZEO); FIRST REGISTRATION: 20150527 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
